Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Trump nominates Susan Monarez to become the next CDC director, says Americans ‘lost confidence’ in agency

by admin March 25, 2025
March 25, 2025
Trump nominates Susan Monarez to become the next CDC director, says Americans ‘lost confidence’ in agency

President Donald Trump has named Susan Monarez as his nominee for the next director of the Centers for Disease Control and Prevention (CDC), calling the candidate ‘a dedicated public servant.’

Monarez, who is currently acting director of the CDC, replaces Trump’s original nominee for the role, Dr. David Weldon. The Trump administration never gave an official reason why Weldon’s nomination was withdrawn earlier this month, but a source familiar with the matter told Fox News Digital that it would have been a ‘futile effort.’

‘It became clear that the votes weren’t there in the Senate for him to get confirmed,’ the source explained. ‘This would have been a futile effort.’

In a Truth Social post published on Monday, Trump wrote that Monarez ‘brings decades of experience championing Innovation, Transparency, and strong Public Health Systems.’

‘She has a Ph.D. from the University of Wisconsin, and PostDoctoral training in Microbiology and Immunology at Stanford University School of Medicine,’ the president wrote. ‘Dr. Monarez understands the importance of protecting our children, our communities, and our future.’

Trump also claimed that Americans have ‘lost confidence’ in the CDC, citing ‘political bias and disastrous mismanagement,’ as reasons why.

‘Dr. Monarez will work closely with our GREAT Secretary of Health and Human Services, Robert Kennedy Jr,’ the president continued. ‘Together, they will prioritize Accountability, High Standards, and Disease Prevention to finally address the Chronic Disease Epidemic and, MAKE AMERICA HEALTHY AGAIN!’

According to Monarez’s CDC biography, she previously worked at the White House in the Office of Science and Technology Policy and on the National Security Council.

‘[She led] efforts to enhance the nation’s biomedical innovation capabilities, including combating antimicrobial resistance, expanding the use of wearables to promote patient health, ensuring personal health data privacy, and improving pandemic preparedness,’ the biography states. ‘She has also held leadership positions at the Department of Homeland Security and has led numerous international cooperative initiatives to promote bilateral and multilateral health innovation research and development.’

Fox News Digital’s Rachel Wolf and Julia Johnson contributed to this report.

This post appeared first on FOX NEWS

previous post
SCOOP: Mike Johnson meeting House Judiciary Committee as GOP mulls response to activist judges blocking Trump
next post
Turkey’s Erdogan continues crackdown on protesters following arrest of main rival on corruption charges

Related Posts

DOUG SCHOEN: Trump’s Iran strategy could ignite long-awaited...

June 23, 2025

Elon Musk claims of ‘pork’ in bill not...

July 2, 2025

Trump’s ‘shock and awe’: Forget first 100 days,...

January 23, 2025

PHOTO GALLERY: Trump in Situation Room during Iran...

June 22, 2025

Senator says RFK Jr told him he agrees...

December 19, 2024

Biden’s team hid the truth about his health...

April 12, 2025

How Trump-blocking judges managed to get past Senate...

March 30, 2025

Gabbard moves presidential daily intelligence brief staff from...

May 15, 2025

GOP senators: Congress should vote on Trump’s potential...

May 9, 2025

China controls over 80% of battery materials crucial...

July 23, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Republican populism craters as Trump stumbles, Democrats surge
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 6, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 6, 2025
  • Republican populism craters as Trump stumbles, Democrats surge

    December 6, 2025
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders

    December 6, 2025
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

    December 6, 2025
  • Abortion restrictions create major roadblock for bipartisan Obamacare subsidy deal in Senate

    December 6, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 7

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,582)
  • Politics (3,117)
  • Stocks (946)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved